Clinical Trials
10 trialsNCT07189806 2025-09-24
MAPLE-UK
Hvivo
Recruiting
NCT03720613 2025-02-12
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
BioDelivery Sciences International
Recruiting
NCT06539169 2024-11-14
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
xCures
Recruiting
NCT03638440 2024-06-17
NACASY
Kyowa Kirin Co., Ltd.
Completed
NCT05579444 2023-12-15
Systems Biology of Gastrointestinal and Related Diseases
Viome
Terminated
NCT04967209 2023-03-31
Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer
Noom Inc.
Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT01928953 2015-07-08
Longitudinal Study of Patients With Opioid-Induced Constipation
AstraZeneca
Completed
NCT01020604 2013-04-30
PROTECT-Z
AstraZeneca
Completed